Phoreus Biotech

Phoreus Biotech provides next-generation, peptide nanocarrier platforms that can revolutionize the development of animal health technologies. Our Branched Amphipathic Peptide Capsules (BAPC™) and Corralling Amphipathic Peptide Colloids (CAPC™) offer substantially increased efficacy in the creation and delivery of genetic vaccines, cancer therapies, antibiotics, and diagnostics.  Current research and commercial entities have prioritized employing nanocarrier technology to both create new applications (e.g., mRNA and plasmid vaccines) and enhance the delivery/efficacy of current chemical/active ingredients (e.g., traditional antibiotics) while reducing negative effects and environmental impact. Our BAPC and CAPC platforms offer significant advantages in developing new commercially viable products and improving established product lines. The current nanocarriers available today have many limitations in these applications, and there are no competitors using self-assembling, customizable peptide nanocarriers that deliver our unique benefits.

Phoreus biotech, founded in 2018 and based in Olathe, Kansas, is a life sciences company specializing in innovative nanocarrier technology for drug and vaccine delivery. The company's core technology, Branched Amphipathic Peptide Capsules (BAPC️), represents a new class of nanocarriers derived from naturally occurring peptides. BAPC️ nanospheres are self-assembled from branched peptides into bilayer-defined capsules, serving as robust delivery vehicles that enhance the absorption of various drugs, including vaccines and therapeutics.

Modern Website Design For Biotech Sales and Partnerships

Peptide Nanocarrier Technology: BAPC and CAPC

Phoreus Biotech Appoints David Schaefer as CEO to Lead Development of Innovative Drug Delivery Nanocarriers

‘Perfect for new mRNA vaccines’: Olathe startup targets biotech toward precision delivery

Biologically protecting plants from pests

Biopesticides

Phoreus Biotechnology

Phoreus Biotech’s new CEO shifts focus to human health market

Phoreus biotech, founded in 2018 and based in Olathe, Kansas, is a life sciences company specializing in innovative nanocarrier technology for drug and vaccine delivery. The company's core technology, Branched Amphipathic Peptide Capsules (BAPC️), represents a new class of nanocarriers derived from naturally occurring peptides. BAPC️ nanospheres are self-assembled from branched peptides into bilayer-defined capsules, serving as robust delivery vehicles that enhance the absorption of various drugs, including vaccines and therapeutics.
Phoreus biotech's technology offers several advantages over traditional nanocarriers, including superior temperature stability, minimal cytotoxicity, and low immunogenicity. Unlike liposomal carriers that break down rapidly in the body, BAPC️ provides optimal stability without accumulating in biological systems. The company's nanocarriers are designed to protect and efficiently deliver therapeutic payloads directly to target cells, potentially improving the efficacy of treatments while reducing side effects.
The company's product portfolio includes three proprietary nanocarrier platforms: Branched Amphipathic Peptide Capsules (BAPC️), Corralling Amphipathic Peptide Capsules (CAPC️), and Amphipathic Peptide Capsules (APC). These technologies have applications in various fields, including mRNA therapy, vaccinations, and transfection techniques. Phoreus biotech's nanocarriers are particularly well-suited for mRNA therapeutics, offering protection for mRNA strands and promoting efficient cellular uptake.
In February 2024, Phoreus biotech appointed David Schaefer as its new Chief Executive Officer to lead the company's development of innovative drug delivery nanocarriers. The company is actively working on expanding its laboratory capabilities and personnel while pursuing collaborative research and industry partnership agreements.

Groundwork BioAg is an Israeli bioagriculture company that produces mycorrhizal inoculants for mainstream agriculture. Its flagship product line, Rootella, consists of highly concentrated mycorrhizal fungi that establish a symbiotic relationship with plant roots, extending their reach into the soil. This symbiosis enables plants to access otherwise unavailable nutrients, especially phosphorus, leading to significant crop yield improvements. Additionally, Rootella enhances plant resilience to various stresses like drought and salinity while reducing fertilizer dependency.
Groundwork BioAg's Mycorrhizal BioPlatform, driven by innovative high-volume production techniques, has been successfully commercialized across major agricultural regions globally. These include the US, Brazil, China, India, Canada, Ukraine, Europe, Asia, and Africa, catering to crops like corn, soybeans, grains, fruits, and vegetables. A standout offering is Tormos, a granular mycorrhizal inoculant tailored for Indian farming practices, developed through a collaboration with ADAMA.
In 2022, Groundwork BioAg raised USD 18 million in Series B funding led by Climate Innovation Capital, underscoring the demand for yield-enhancing biologicals that sequester carbon and promote regenerative agriculture. The company's technology enables conventional and regenerative farmers to achieve higher profitability while permanently sequestering carbon in their fields. Groundwork BioAg has also launched the Rootella Carbon program in 2023, aiming to sequester one gigaton of CO2 within a decade through its mycorrhizal inoculants.
Key customers and partnerships
In 2023, Groundwork BioAg expanded its North American team by appointing Andrew Duff as General Manager to accelerate the adoption of Rootella mycorrhizal inoculants among mainstream growers in the US.
In June 2022, Groundwork BioAg partnered with ADAMA, a leading global crop protection company, to offer the Tormos mycorrhizal inoculant in India. This collaboration leverages ADAMA's extensive farmer network and Groundwork BioAg's Mycorrhizal BioPlatform to provide cost-effective solutions to Indian growers.

Groundwork BioAG

Solasta Bio is a Glasgow-based agritech company specializing in the development of peptide-based bioinsecticides for crop protection. Founded in 2020 as a spin-out from the University of Glasgow, the company has created the world's first technology platform for producing neuropeptide-based Insect Control Agents (ICAs) derived from nature rather than synthetic chemistry.
These ICAs are designed to disrupt targeted physiological processes in insect pests, effectively controlling them while leaving beneficial pollinators like bees and other non-target species unharmed. Solasta Bio's solutions offer unique insect specificity, proven efficacy on par with traditional chemical insecticides, and an environmentally friendly, biodegradable approach that does not accumulate residues in nature.
Solasta Bio's platform enables the company to target a wide spectrum of pests, including those resistant to synthetic chemistries. The company aims to bring its first ICA products to market by 2027/2028, approximately half the time traditionally required for synthetic pest control products. Its technology is patent-protected, and an additional patent application is pending.
In February 2024, Solasta Bio announced the successful completion of over 20 field trials across Europe, the UK, and the US, demonstrating the efficacy and safety of its ICAs across various crops and pests, including aphids, Spotted Wing Drosophila, caterpillars, and leafhoppers.

Solasta Bio

Enko Chem, Inc. is a crop health company focused on developing sustainable crop solutions to address global food security challenges. The company utilizes its proprietary ENKOMPASS technology platform, which combines DNA-encoded library screening, machine learning, and structure-based design, to discover novel crop protection chemistries. This approach enables Enko to rapidly identify new, better-performing, and more targeted molecules across various categories of crop protection products.
Enko's current pipeline is led by a range of herbicides designed to break cycles of weed and pest resistance while reducing environmental impact compared to existing solutions. The company aims to provide effective crop protection solutions that help growers adapt to and mitigate challenges exacerbated by climate change, such as pesticide-resistant weeds, fungus, and pests.
Since its inception in 2017, Enko has generated hundreds of leading molecules through its technology platform. In January 2023, the company announced an USD 80 million Series C funding round, bringing its total capital raised to USD 150 million. The additional funds will be utilized to advance Enko's product pipeline and support the company's efforts to bring new crop protection solutions to market.

Enko Chem

BioPhero is a Denmark-based company that has developed a pioneering and highly efficient yeast fermentation process for manufacturing pheromones at significantly lower costs and with fewer production steps compared to traditional chemical synthesis methods. Pheromones are compounds used in integrated pest management programs for controlling insect populations by disrupting the mating process, thereby reducing egg-laying and decreasing the next generation of the target insect species. BioPhero's patented fermentation technology allows for the sustainable and cost-effective production of pheromones, expanding their potential application from specialty crops like fruits and vegetables to large-scale row crops such as corn, soybeans, and rice.
Through its innovative bioprocessing platform, BioPhero aims to make pheromones widely available and contribute to sustainable agriculture by offering an environmentally friendly alternative to conventional insecticides. The company's pheromone products are highly specific to target pests, promoting biodiversity and posing no threat to pollinators or beneficial insects. FMC Corporation, a leading agricultural sciences company, acquired BioPhero in July 2022 for approximately USD 200 million, integrating its pheromone platform into FMC's biologicals business. FMC projects revenue from pheromones and pheromone-based insect control products to reach approximately USD 1 billion with above company-average EBITDA margin by 2030.

BioPhero

Redag Crop Protection is a biotechnology research and development company focused on developing novel crop protection products. The company's core technology is the Redox Switch platform, which allows for the creation of new compounds by modifying the oxidation state of existing best-in-class products. This approach provides Redag Crop Protection with a pipeline of candidates across multiple high-value applications in the crop protection industry.
The Redox Switch platform offers several advantages. It enables the company to secure intellectual property rights around existing products by creating structurally similar but chemically distinct compounds. These new compounds share similarities with well-characterized parent compounds, reducing the risk profile, development time, testing redundancy, and overall cost of bringing products to market. Additionally, the structural similarity to existing product classes means that Redag Crop Protection can leverage current manufacturing assets, further reducing market entry costs.

Redag Crop Protection

Companies that use microscopic living organisms (such as viruses, bacteria or nematodes) or toxins produced by these organisms to act as pest control. This also includes companies developing technology platforms to use microorganism chemistry to develop different kinds of microbial pesticides.

Companies that develop pesticide substances produced by plants as a result of genetic manipulation. These companies use technology such as genetic engineering to derive natural substances that plants can produce to kill pests that feed on them.

Companies that use machine learning and artificial intelligence technologies to develop plant-based replacements to synthetic chemical. These companies develop biochemicals that use naturally occurring substances such as pheromones, and insect attractants to trap and control pests in plants.  This also includes companies that offer plant intelligence for creating biochemicals.

Companies that use naturally occurring plant materials such as Azadirachtin, nicotinoids, natural pyrethrins, rotenoids,  and neem products in full or dilute form for pest and insect controls.

Companies that use natural enemies or predators like lady beetle, true bug, lacewings or parasitoids to protect the plants from pests.

Companies that use natural resources such as diatomaceous earth, mineral oil, water, minerals such as sulfur, potassium, or even organic acids for controlling various types of pests.

Companies that use biologically-derived substances such as microorganisms, seaweed extracts, and other organic matter that are applied to the plants or the soil to improve nutrient uptake, enhance tolerance of plant stress, and in turn improve crop growth and yield.

Provides natural alternatives to chemical pesticides

Processes often use AI and machine learning-based tech platforms to formulate biopesticides

Phoreus Biotechnology

Sources

About EDGE

Contact Us

Resources

Area of Focus

Technology Research Made Effortless